Foresite Capital Management VI LLC
WEST HOLLYWOOD, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$566.4M2026 Q3
Positions22
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.77.7%
What Changed This Quarter?
Top Holdings
CGON
CG Oncology
26.4%
KRSA
Korsana Biosciences
8.1%
LTGO
Latigo Biotherapeutics
6.5%
SPTX
Seaport Therapeutics
6.3%
DNLI
Denali Therapeutics
5.9%
PBLS
Parabilis Medicines
5.7%
ALMS
Alumis
5.5%
AGIO
Agios Pharmaceuticals
4.9%
New / Increased
4 new · 5 increased
KRSANEW
Korsana Biosciences
8.1%
LTGONEW
Latigo Biotherapeutics
6.5%
OBXNEW
Obsidian Therapeutics
2.2%
Entera BioNEW
Entera Bio
0.6%
AVBP
ArriVent BioPharma
2.6%
+62.7%
ZURA
Zura Bio
1.3%
+290.4%
DNLI
Denali Therapeutics
5.9%
+15.8%
IRON
Disc Medicine
0.8%
+6958.8%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.